Determination of binding characteristics as a measure for effective albumin using different methods.

[1]  R. Guzzi,et al.  Interactive multiple binding of oleic acid, warfarin and ibuprofen with human serum albumin revealed by thermal and fluorescence studies , 2022, European Biophysics Journal.

[2]  Daniel J. Rosenberg,et al.  Albumin in patients with liver disease shows an altered conformation , 2021, Communications biology.

[3]  M. Bartolini,et al.  Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications , 2021, Hepatology.

[4]  Huan‐Xiang Zhou,et al.  Fatty Acids Compete with Aβ in Binding to Serum Albumin by Quenching Its Conformational Flexibility. , 2019, Biophysical journal.

[5]  A. Gasbarrini,et al.  Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial , 2018, The Lancet.

[6]  J. Stange,et al.  Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin Dialysis , 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[7]  E. Bourdon,et al.  Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide , 2018, The Journal of Biological Chemistry.

[8]  J. Hartmann,et al.  Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification , 2018, PloS one.

[9]  M. Otagiri,et al.  Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations. , 2015, Journal of pharmaceutical sciences.

[10]  M. Naldi,et al.  Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis , 2014, Hepatology.

[11]  D. Giustarini,et al.  Cigarette smoke induces alterations in the drug-binding properties of human serum albumin. , 2014, Blood cells, molecules & diseases.

[12]  R. Stauber,et al.  Human Nonmercaptalbumin‐2: A Novel Prognostic Marker in Chronic Liver Failure , 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[13]  M. Otagiri,et al.  Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases , 2014, PloS one.

[14]  R. Jalan,et al.  Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications , 2013, Hepatology.

[15]  R. Stauber,et al.  Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. , 2013, Journal of hepatology.

[16]  D. S. Hage,et al.  Review: Glycation of human serum albumin. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[17]  E. Bourdon,et al.  Impaired drug-binding capacities of in vitro and in vivo glycated albumin. , 2012, Biochimie.

[18]  C. Shearman,et al.  Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. , 2011, Metabolism: clinical and experimental.

[19]  E. Reisinger,et al.  Industrial stabilizers caprylate and N‐acetyltryptophanate reduce the efficacy of albumin in liver patients , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  S. Curry,et al.  Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin , 2011, Journal of structural biology.

[21]  D. S. Hage,et al.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. , 2010, Journal of pharmaceutical and biomedical analysis.

[22]  K. Schnurr,et al.  Fatty acid binding sites of human and bovine albumins: differences observed by spin probe ESR. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[23]  Roger Williams,et al.  Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality , 2009, Hepatology.

[24]  M. Davies,et al.  What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. , 2009, Chemical research in toxicology.

[25]  S. Era,et al.  HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. , 2009, International journal of peptide and protein research.

[26]  R. Stauber,et al.  Oxidative damage of albumin in advanced liver disease. , 2008, Biochimica et biophysica acta.

[27]  H. Kaneto,et al.  Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. , 2008, Endocrine journal.

[28]  P. Taboada,et al.  Effect of solvation on the structure conformation of human serum albumin in aqueous–alcohol mixed solvents , 2007 .

[29]  R. Stauber,et al.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties , 2007, British journal of pharmacology.

[30]  S. Kazmierczak,et al.  Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. , 2006, Clinical chemistry.

[31]  T. Amisaki,et al.  Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids , 2006, Proteins.

[32]  S. Curry,et al.  Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. , 2006, Journal of molecular biology.

[33]  P. Ascenzi,et al.  Allosteric modulation of drug binding to human serum albumin. , 2006, Mini reviews in medicinal chemistry.

[34]  S. Curry,et al.  Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Toru Maruyama,et al.  The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. , 2003, Biochimica et biophysica acta.

[36]  G. Hersmann,et al.  Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. , 2002, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[37]  S. Era,et al.  Simple and sensitive high-performance liquid chromatographic method for the investigation of dynamic changes in the redox state of rat serum albumin. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[38]  M. Otagiri,et al.  Effect of Oxidative Stress on the Structure and Function of Human Serum Albumin , 2001, Pharmaceutical Research.

[39]  S. Mitzner,et al.  Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers. , 2001, Zeitschrift fur Gastroenterologie.

[40]  P. Brick,et al.  Fatty acid binding to human serum albumin: new insights from crystallographic studies. , 1999, Biochimica et biophysica acta.

[41]  P. Sadler,et al.  A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy. , 1994, European journal of biochemistry.

[42]  R G Reed,et al.  The albumin receptor effect may be due to a surface-induced conformational change in albumin. , 1989, The Journal of biological chemistry.

[43]  G. H. Faber,et al.  Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin. , 1985, Journal of pharmaceutical sciences.

[44]  G. Marsche,et al.  Redox state of human serum albumin in terms of cysteine-34 in health and disease. , 2010, Methods in enzymology.

[45]  M. Otagiri,et al.  Kinetic studies of covalent binding between N-acetyl-L-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymer-based column. , 2004, Drug metabolism and pharmacokinetics.